Royal Bank of Canada’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-88,079
| Closed | -$7.03M | – | 7967 |
|
|
2021
Q1 | $7.03M | Sell |
88,079
-458,498
| -84% | -$35.8M | ﹤0.01% | 2001 |
|
|
2020
Q4 | $43.1M | Sell |
546,577
-2,005
| -0.4% | -$118K | 0.01% | 769 |
|
|
2020
Q3 | $24.1M | Buy |
548,582
+4,283
| +0.8% | +$211K | 0.01% | 979 |
|
|
2020
Q2 | $24.1M | Buy |
544,299
+131,243
| +32% | +$4.9M | 0.01% | 944 |
|
|
2020
Q1 | $14.8M | Buy |
413,056
+47,731
| +13% | +$2.71M | 0.01% | 1076 |
|
|
2019
Q4 | $25.9M | Buy |
365,325
+9,558
| +3% | +$693K | 0.01% | 992 |
|
|
2019
Q3 | $26.6M | Buy |
355,767
+10,649
| +3% | +$903K | 0.01% | 898 |
|
|
2019
Q2 | $27.8M | Buy |
345,118
+29,059
| +9% | +$2.04M | 0.01% | 882 |
|
|
2019
Q1 | $21.1M | Sell |
316,059
-1,640
| -0.5% | -$124K | 0.01% | 1029 |
|
|
2018
Q4 | $23.7M | Sell |
317,699
-33,859
| -10% | -$2.8M | 0.01% | 891 |
|
|
2018
Q3 | $32.4M | Sell |
351,558
-59,683
| -15% | -$5.68M | 0.01% | 836 |
|
|
2018
Q2 | $40.5M | Sell |
411,241
-72,101
| -15% | -$8.06M | 0.02% | 658 |
|
|
2018
Q1 | $53.8M | Sell |
483,342
-9,774
| -2% | -$1.1M | 0.02% | 550 |
|
|
2017
Q4 | $50.7M | Sell |
493,116
-33,294
| -6% | -$3.32M | 0.02% | 596 |
|
|
2017
Q3 | $49.6M | Sell |
526,410
-82,704
| -14% | -$6.53M | 0.02% | 571 |
|
|
2017
Q2 | $47.5M | Sell |
609,114
-6,174
| -1% | -$464K | 0.02% | 565 |
|
|
2017
Q1 | $49.3M | Buy |
615,288
+17,600
| +3% | +$1.4M | 0.03% | 521 |
|
|
2016
Q4 | $47.1M | Sell |
597,688
-7,790
| -1% | -$605K | 0.03% | 536 |
|
|
2016
Q3 | $47.2M | Sell |
605,478
-43,451
| -7% | -$3.15M | 0.03% | 530 |
|
|
2016
Q2 | $44.6M | Sell |
648,929
-62,294
| -9% | -$4.3M | 0.03% | 526 |
|
|
2016
Q1 | $50.8M | Sell |
711,223
-112,565
| -14% | -$7.07M | 0.03% | 452 |
|
|
2015
Q4 | $51.2M | Sell |
823,788
-29,671
| -3% | -$1.81M | 0.03% | 441 |
|
|
2015
Q3 | $48.4M | Sell |
853,459
-23,977
| -3% | -$1.27M | 0.04% | 364 |
|
|
2015
Q2 | $47.1M | Sell |
877,436
-78,442
| -8% | -$3.82M | 0.03% | 404 |
|
|
2015
Q1 | $45.4M | Sell |
955,878
-28,961
| -3% | -$1.28M | 0.03% | 426 |
|
|
2014
Q4 | $42.6M | Sell |
984,839
-95,787
| -9% | -$3.91M | 0.03% | 488 |
|
|
2014
Q3 | $37.2M | Sell |
1,080,626
-7,110
| -0.7% | -$251K | 0.03% | 488 |
|
|
2014
Q2 | $39.8M | Buy |
1,087,736
+15,557
| +1% | +$528K | 0.03% | 463 |
|
|
2014
Q1 | $36.2M | Sell |
1,072,179
-81,594
| -7% | -$2.69M | 0.03% | 460 |
|
|
2013
Q4 | $39.1M | Sell |
1,153,773
-2,965
| -0.3% | -$103K | 0.03% | 456 |
|
|
2013
Q3 | $36.8M | Buy |
1,156,738
+158,719
| +16% | +$4.22M | 0.03% | 450 |
|
|
2013
Q2 | $22.5M | Buy |
+998,019
| New | +$21.6M | 0.02% | 602 |
|
Royal Bank of Canada's CMD Position: Q2 2021 in Review
Royal Bank of Canada sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 88,079 shares — an estimated $7.03M sold.
Royal Bank of Canada first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $53.8M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Royal Bank of Canada reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Royal Bank of Canada sold 88,079 Cantel Medical Corporation shares in Q2 2021, an estimated $7.03M.
- Royal Bank of Canada first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Royal Bank of Canada's Cantel Medical Corporation position peaked at $53.8M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.